the anticipated progress of our and our collaborators research, development and clinical programs, including the timing of regulatory submissions and whether future clinical trials will achieve similar results to clinical trials that we have successfully concluded

Exhibit 10.29

2009 COMPENSATION INFORMATION FOR REGISTRANT’S EXECUTIVE OFFICERS

     The table below provides information regarding (i) the base salary of each executive officer of GTx, Inc. (the “Company”), effective as of January 1, 2009, and (ii) the target cash bonus award for each of the Company’s executive officers under the Company’s Executive Bonus Compensation Plan for Fiscal 2009, expressed as a percentage of applicable base salary:

				2009		2009
				Annual		Target
Executive Officer		Title		Salary($)		Bonus(%)
Mitchell S. Steiner		Chief Executive Officer and Vice-Chairman of the Board of Directors		525,000		65
Marc S. Hanover		President and Chief Operating Officer		456,750		55
Ronald A. Morton, Jr.		Vice President, Chief Medical Officer		452,025(1)		30
James T. Dalton		Vice President, Preclinical Research and Development		400,000(1)		30
Henry P. Doggrell		Vice President, General Counsel and Secretary		301,281		30
Mark E. Mosteller		Vice President, Chief Financial Officer and Treasurer		298,083		30
Gregory A. Deener		Vice President, Sales and Marketing		257,985		30